AZN vs XOSWW · P/E 28, $288.38B cap vs rev $56.0M
AstraZeneca PLC (AZN) versus Xos Equity Warrants (XOSWW) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Xos Equity Warrants (XOSWW) is a automobiles & auto parts company listed on NASDAQ.
AZN does not have a complete income-statement cache yet.
Latest reported XOSWW revenue for 2024-12-31 was $56.0M. Net income was -$50.2M. Revenue was up 25.7% from 2023-12-31 to 2024-12-31. XOSWW currently screens at market cap $0.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. XOSWW currently screens at market cap $0.
Not investment advice. Open the AZN and XOSWW stock pages for the full models.
Not investment advice.